| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.02B | 28.92B | 32.70B | 31.35B | 38.75B | 27.14B |
| Gross Profit | 7.11B | 7.90B | 12.79B | 9.03B | 14.87B | 9.82B |
| EBITDA | 5.89B | 6.44B | 12.76B | 8.45B | 13.46B | 9.59B |
| Net Income | 2.65B | 2.81B | 3.42B | 2.31B | 3.75B | 2.22B |
Balance Sheet | ||||||
| Total Assets | 165.57B | 168.51B | 179.31B | 193.93B | 207.71B | 194.88B |
| Cash, Cash Equivalents and Short-Term Investments | 27.32B | 26.85B | 27.85B | 31.16B | 39.23B | 29.94B |
| Total Debt | 58.75B | 59.77B | 58.83B | 58.94B | 65.08B | 57.93B |
| Total Liabilities | 85.24B | 90.22B | 101.85B | 117.14B | 126.35B | 112.81B |
| Stockholders Equity | 49.16B | 47.57B | 46.60B | 45.52B | 47.44B | 43.68B |
Cash Flow | ||||||
| Free Cash Flow | 177.23M | 304.68M | 3.03B | -2.09B | 936.19M | 1.53B |
| Operating Cash Flow | 4.08B | 4.81B | 4.35B | -1.53B | 7.93B | 4.54B |
| Investing Cash Flow | -121.67M | -6.92B | -4.04B | -3.07B | -2.58B | -4.89B |
| Financing Cash Flow | -5.21B | -1.38B | -3.34B | -4.56B | 2.91B | -3.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $25.20B | 6.30 | 6.18% | 4.23% | 7.45% | 11.56% | |
69 Neutral | $29.46B | 10.89 | 4.43% | 5.11% | 6.95% | 24.07% | |
67 Neutral | $14.93B | 5.64 | 5.58% | 6.70% | -7.44% | -18.48% | |
66 Neutral | $43.25B | 7.46 | 6.26% | 4.65% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
46 Neutral | HK$1.17B | -2.47 | -4.99% | 4.15% | 13.04% | -27.89% | |
42 Neutral | $39.10B | -8.15 | -3.65% | 0.41% | -8.93% | -698.78% |
Shanghai Industrial Holdings, through its subsidiary Wing Fat Printing, has entered into a Procurement Framework Agreement with Shanghai Pharmaceuticals Holding. This agreement, effective from January 1, 2026, to December 31, 2026, allows Wing Fat Group to supply printed packaging materials for pharmaceutical products to Shanghai Pharmaceuticals Holding Group, subject to an annual procurement cap. The agreement is classified as a continuing connected transaction under Hong Kong’s Listing Rules, requiring only reporting, announcement, and annual review due to its size. This strategic move aligns with the company’s efforts to strengthen its market position in the pharmaceutical packaging sector.
The most recent analyst rating on (HK:0363) stock is a Hold with a HK$15.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings, a company indirectly controlled by the Shanghai Government, has announced a proposed internal reorganization. The reorganization involves changing the registered owner of its immediate controlling shareholder, SIIC, to Golden Bell. Despite this change, the ultimate control of the company remains with the Shanghai Government, as all entities involved are wholly owned by it. This announcement is made voluntarily, and stakeholders are advised to exercise caution when dealing with the company’s securities.
The most recent analyst rating on (HK:0363) stock is a Hold with a HK$15.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings Limited, a company listed on the Hong Kong Stock Exchange, has announced a change in its auditing firm due to mandatory rotation regulations. Deloitte Touche Tohmatsu has resigned as the auditor, and Ernst & Young has been appointed as the new auditor. The transition is not expected to impact the company’s financial statement audits for the year ending December 2025.
The most recent analyst rating on (HK:0363) stock is a Hold with a HK$15.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings, through its wholly-owned subsidiary SIHL Finance, has extended the repayment dates for three existing loans to a joint venture company. These extensions, which move the due dates to September 2026, are part of the company’s strategic financial management. The aggregate size of these loans exceeds 5% but is less than 25% of the company’s applicable percentage ratio, classifying the transaction as discloseable under Hong Kong’s Listing Rules. This move reflects the company’s ongoing efforts to manage its financial commitments and maintain operational stability.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.80 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings Limited has announced the appointment of two new independent non-executive directors, Prof. Zhang and Mr. Tang, and changes to its board committee members. Both appointees have confirmed their independence, with no financial or other interests in the company, ensuring compliance with the Listing Rules. This move is expected to strengthen the company’s governance structure and enhance its strategic oversight.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.80 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings Limited has announced significant changes to its board of directors, appointing Prof. Zhang Qian and Mr. Tang, William Harry Jiasheng as Independent Non-Executive Directors, and Mr. Yuen Tin Fan, Francis as the chairman of the Remuneration and Nomination Committees. These appointments are expected to enhance the company’s governance structure and strategic oversight, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings Limited has announced the composition of its Board of Directors, which includes eight members with defined roles and responsibilities. This announcement is significant as it outlines the leadership structure of the company, potentially impacting its strategic direction and governance, which is crucial for stakeholders and investors.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings Limited announced an interim cash dividend of HKD 0.42 per share for the six months ending June 30, 2025. The dividend will be paid on October 15, 2025, with the record date set for September 26, 2025. This announcement reflects the company’s ongoing commitment to delivering shareholder value and may positively influence investor sentiment.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings Limited reported an 8.6% decrease in revenue and a 13.2% drop in profit for the first half of 2025, mainly due to reduced sales in its real estate sector and impairments in property values. Despite these challenges, the company is leveraging favorable national policies to explore new growth avenues and optimize its business operations. The infrastructure and environmental protection segment, particularly the toll road business, remains a key profit driver, although it also saw an 11.6% decline in profit. The company is focusing on enhancing its water-treatment and toll road operations, aligning with national directives, and preparing for the National Expressway Maintenance and Management Performance Evaluation to improve its management capabilities.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings Limited has scheduled a Board of Directors meeting on August 28, 2025, to approve the interim results for the first half of 2025 and consider an interim dividend. This announcement may impact the company’s financial outlook and shareholder returns, reflecting its ongoing operational strategies and market positioning.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$12.40 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.